TEON THERAPEUTICS INC has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are SUFFREN STE PARTI BREVETS, VENATORX PHARMACEUTICALS INC and BETA CAT PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Special acyclic compounds | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Liu Jiwen | 10 |
#2 | Elzein Elfatih | 9 |
#3 | Jiwen Liu | 1 |
#4 | Elfatih Elzein | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021011670A1 | Adenosine a2a receptor antagonists and uses thereof | |
WO2020251957A1 | Prostaglandin e2 receptor 4 antagonists and uses thereof | |
BR112020018158A2 | adenosine receptor antagonists and uses thereof |